Aph-1c Activators

Chemical activators of aph1 homolog C, gamma secretase subunit, can act in various ways to influence the protein's activity. DAPT, a gamma-secretase inhibitor, can activate the aph1 homolog C, gamma secretase subunit by inducing a conformational change in the enzyme complex at sub-inhibitory concentrations. Similarly, L-685,458, as a transition-state analog inhibitor, can bind to the enzyme and alter its conformation, stabilizing a productive conformation for substrate processing, which leads to activation. Semagacestat and Begacestat might also lead to the activation of the aph1 homolog C, gamma secretase subunit by stabilizing an active enzyme complex form through their binding interactions. Avagacestat is designed to interact with gamma-secretase and may induce an active conformation of the subunit, thereby promoting its activation.

Furthermore, BMS-708163 targets gamma-secretase and can promote an active conformation of aph1 homolog C, gamma secretase subunit, thus activating the enzyme complex. PF-3084014, while primarily an inhibitor, can engage with the gamma-secretase in a way that potentially stabilizes the subunit in an active form, enhancing its activity. LY-411575 can activate aph1 homolog C, gamma secretase subunit by altering the conformation of the enzyme complex to favor substrate cleavage. MK-0752, another inhibitor, can activate the enzyme by promoting its active conformation. RO4929097 can activate aph1 homolog C, gamma secretase subunit by inducing a conformational change that results in increased activity. Likewise, Compound E, despite its inhibitory nature, can bind in a manner that activates the subunit through conformational modulation. Lastly, Nirogacestat binds to gamma-secretase and can activate aph1 homolog C, gamma secretase subunit by inducing a shift to a more active enzyme conformation.